Shingrix References and Resources
Shingrix Vaccine Safety
Clinical and Vaccination Information
- Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022.
- Clinical Considerations for Use of Recombinant Zoster Vaccine (RZV, Shingrix) in Immunocompromised Adults Aged ≥19 Years | CDC
- You Call The Shots – Intramuscular Shingrix vaccination (recombinant zoster vaccine)
- Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines, 2018.
- Shingles (Herpes Zoster) Clinical Overview
- Shingrix Information for Healthcare Professionals
- Zoster section, Varicella Chapter, The Pink Book: Course Textbook (13th Edition, 2015)
Materials for Patients
- CDC’s Shingles Website
- What Everyone Should Know about Shingles Vaccine (Shingrix)
- Resources for Older Adults
Other References and Resources
Page last reviewed: January 24, 2022
Content source: National Center for Immunization and Respiratory Diseases